Some COVID-19 patients in Edmonton begin potential trial treatment, apabetalone, an Alberta-developed drug
An Alberta-developed drug heralded as a potential oral treatment for COVID-19 has begun testing at Edmonton’s University of Alberta hospital.
Source: edmontonjournal.com